Related Experiment Video
Updated: Jul 1, 2026

Optimizing Tubulin Yield from Porcine Brain Tissue
Published on: October 11, 2024
Structural insight into the inhibition of tubulin by vinca domain peptide ligands
Anthony Cormier1, Matthieu Marchand, Raimond B G Ravelli
1Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, Bat. 34, 1 avenue de la Terrasse, 91198 Gif-sur-Yvette, France.
Abstract:
The tubulin vinca domain is the target of widely different microtubule inhibitors that interfere with the binding of vinblastine. Although all these ligands inhibit the hydrolysis of GTP, they affect nucleotide exchange to variable extents. The structures of two vinca domain antimitotic peptides--phomopsin A and soblidotin (a dolastatin 10 analogue)--bound to tubulin in a complex with a stathmin-like domain show that their sites partly overlap with that of vinblastine and extend the definition of the vinca domain. The structural data, together with the biochemical results from the ligands we studied, highlight two main contributors in nucleotide exchange: the flexibility of the tubulin subunits' arrangement at their interfaces and the residues in the carboxy-terminal part of the beta-tubulin H6-H7 loop. The structures also highlight common features of the mechanisms by which vinca domain ligands favour curved tubulin assemblies and destabilize microtubules.
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Pinching-off of Coated Vesicles
Destabilization of Microtubules
Inhibition of CDK Activity
Inhibition of Cdk Activity
